Discovery of Novel Small Molecules for Heart Failure Therapy Using Cultured Cardiomyocyte by High Throughput Screening Assay
Main Authors: | Satoshi Shimizu, Miho Yamada, Takahiro Katagiri, Yoichi Sunagawa, Yasufumi Katanasaka, Yusuke Miyazaki, Masafumi Funamoto, Sari Nurmila, Kana Shimizu, Naohisa Ogo, Akira Asai, Koji Hasegawa, Tatsuya Morimoto |
---|---|
Format: | Article |
Language: | English |
Published: |
Radcliffe Medical Media
2021-12-01
|
Series: | European Cardiology Review |
Online Access: | https://www.ecrjournal.com/articleindex/ecr.2021.16.PO10 |
Similar Items
-
Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes
by: Yoichi Sunagawa, et al.
Published: (2021-10-01) -
Curcumin, an Inhibitor of p300-HAT Activity, Suppresses the Development of Hypertension-Induced Left Ventricular Hypertrophy with Preserved Ejection Fraction in Dahl Rats
by: Yoichi Sunagawa, et al.
Published: (2021-07-01) -
Histone Acetylation Domains Are Differentially Induced during Development of Heart Failure in Dahl Salt-Sensitive Rats
by: Masafumi Funamoto, et al.
Published: (2021-02-01) -
Anti-inflammatory Action of Curcumin and Its Use in the Treatment of Lifestyle-related Diseases
by: Kana Shimizu, et al.
Published: (2019-07-01) -
The Polyunsaturated Fatty Acids EPA and DHA Prevent Myocardial Infarction-induced Heart Failure by Inhibiting p300-HAT Activity in Rats
by: Yoichi Sunagawa, et al.
Published: (2021-12-01)